DNA POLYMERASE MUTANT SUITED TO NUCLEIC ACID AMPLIFICATION FROM RNA

    公开(公告)号:US20240309341A1

    公开(公告)日:2024-09-19

    申请号:US18660667

    申请日:2024-05-10

    申请人: Takara Bio Inc.

    IPC分类号: C12N9/12

    CPC分类号: C12N9/1252 C12Y207/07007

    摘要: Provided are: a DNA polymerase mutant having reverse transcriptase activity, the DNA polymerase mutant including a sequence consisting of twelve specific amino acids A1-A12, wherein the DNA polymerase mutant having reverse transcriptase activity is characterized in that the A3 and/or A10 amino acid is substituted by a basic amino acid residue different from that prior to the introduction of mutation; a kit and a composition including the DNA polymerase; a method for producing the DNA polymerase; and a method for modifying an existing DNA polymerase having reverse transcriptase activity.

    DNA polymerase mutant suited to nucleic acid amplification from RNA

    公开(公告)号:US12018294B2

    公开(公告)日:2024-06-25

    申请号:US17257986

    申请日:2019-07-03

    申请人: TAKARA BIO INC.

    IPC分类号: C12N9/12

    CPC分类号: C12N9/1252 C12Y207/07007

    摘要: Provided are: a DNA polymerase mutant having reverse transcriptase activity, the DNA polymerase mutant including a sequence consisting of twelve specific amino acids A1-A12, wherein the DNA polymerase mutant having reverse transcriptase activity is characterized in that the A3 and/or A10 amino acid is substituted by a basic amino acid residue different from that prior to the introduction of mutation; a kit and a composition including the DNA polymerase; a method for producing the DNA polymerase; and a method for modifying an existing DNA polymerase having reverse transcriptase activity.